Ropes & Gray has advised Rallybio. Wilson Sonsini Goodrich & Rosati has advised Candid Therapeutics on patent matters. Rallybio Corporation and Candid Therapeutics have entered into...
Rallybio to Acquire Candid Therapeutics in Merger and $505 Million Financing
Gilead Sciences Acquires Arcellx in $7.8 Billion Deal
Wilson Sonsini Goodrich & Rosati has advised Arcellx on the transaction, and Ropes & Gray LLP has advised Gilead Sciences. Gilead Sciences (Nasdaq: GILD) has entered...
Korsana Biosciences and Cyclerion Therapeutics Announce All-Stock Merger and $380 Million Financing
Gibson Dunn has advised Korsana Biosciences. Ropes & Gray has advised Cyclerion Therapeutics. Korsana Biosciences and Cyclerion Therapeutics, Inc. have entered into a definitive agreement to...
Eli Lilly Acquires Ventyx Biosciences for $1.2 Billion to Enhance Inflammatory Disease Portfolio
Ropes & Gray has advised Eli Lilly and Company. Wilson Sonsini Goodrich & Rosati has advised Ventyx Biosciences. Gibson Dunn has advised Jefferies LLC as lead...
Lumexa Imaging Launches US$462.5 Million Initial Public Offering
Sidley has advised Lumexa Imaging Holdings, Inc. Ropes & Gray has represented the underwriters. Lumexa Imaging Holdings, Inc. has completed its initial public offering, issuing 25,000,000...
Berkshire Partners Invests in United Flow Technologies
Ropes & Gray has advised Berkshire Partners. King & Spalding LLP has advised H.I.G. Capital and United Flow Technologies. Berkshire Partners has made a strategic growth...
Nexthink Receives Majority Investment from Vista Equity Partners
Ropes & Gray has advised Nexthink, and Kirkland & Ellis has advised Vista Equity Partners. Nexthink, a leader in Digital Employee Experience (DEX) management, has entered...
Eli Lilly Announces Acquisition of Adverum Biotechnologies for Up to $1.3 Billion
Ropes & Gray has advised Eli Lilly and Company, and Cooley has advised Adverum Biotechnologies, Inc. Eli Lilly and Company has entered into a definitive agreement...
Kailera Therapeutics Raises $600 Million in Series B Financing
Ropes & Gray has advised Bain Capital on the transaction. Kailera Therapeutics, a clinical-stage biopharmaceutical company specializing in obesity therapies, has announced the closing of a...
Novo Nordisk to Acquire Akero Therapeutics for Up to $5.2 Billion
Ropes & Gray has advised Novo Nordisk, and Kirkland & Ellis has advised Akero Therapeutics. Novo Nordisk has entered into a definitive agreement to acquire Akero...
DB Insurance Acquires Fortegra for $1.65 Billion
Ropes & Gray and Sidley Austin have advised Tiptree and Fortegra respectively; Latham & Watkins has advised DB Insurance. DB Insurance Co., Ltd. has reached an...
Tukios Acquires Batesville’s Funeral Home Website Hosting Services
Ropes & Gray has advised Tukios on the transaction. Tukios, a leading provider of website technology solutions for the funeral profession and a portfolio company of...